Pregenen
Seattle
About Pregenen
Pregenen designs and engineers molecules critical to a new generation of cell-based therapies for unmet medical needs. They work with our partners to apply their tools, services and reagents to increase the reliability, efficacy and safety of a new wave of therapies harnessing the specificity and functional power of molecules and cells produced by the body.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: pregenen.com
- Phone: 2065452897
Social Profiles
Canonical: https://fsome.com/organization/pregenen-2161538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.